Overview
Part of Dana-Farber Cancer Institute and affiliated with Harvard Medical School, the Belfer Institute is built upon a tradition of research excellence and a history of medical innovation. Our scientists are leaders in their fields and our organized and integrated research teams leverage a broad network of research centers of excellence. As a result, we are at the forefront of developing the next generation of cancer therapies. The Belfer Institute recently named two new scientific co-directors and a head of research, adding to its world-class team and continuing to grow its expertise.
In the News
Video Commentary From Dr. Pasi Janne on New Lung Cancer Study at ASCO 2012
Study reports first success of targeted therapy in most common genetic subtype of non-small cell lung cancer
Dana-Farber's Belfer Institute for Applied Cancer Science to Present at AACR Special Conference Molecular Targeted Therapies: Mechanisms of Resistance